In this research article the authors review the efficacy and safety of radiosurgery for melanoma brain metastases in patients treated with ipilimumab .
Browsing: Journals > Melanoma Management
In this from editorial Melanoma Management the authors explore the use of vaccines in combination with dasatinib for the treatment of stage IIIB–IV melanoma.
Could dendritic cell vaccines be a promising therapeutic strategy for advanced melanoma? Read more in this article from Melanoma Management.
Could long-noncoding RNAs be utilized as novel circulating biomakers to aid the detection, diagnosis and prognosis of melanoma?
Meenhard Herlyn, Caspar Wistar Professor for Melanoma Research and Director of the Melanoma Research Center at The Wistar Institute (PA, USA) and Founding President of the Society for Melanoma Research speaks to Melanoma Management about his 40 years in melanoma research.
The author discusses their opinion on the recent advancements of treating melanoma, covering systemic immunotherapies and the promising findings for anti-PD-1 agents combined with ipilimumab.
Low-dose brachytherapy studies have demonstratedequivalent local and distant tumor control with reduced radiation complications – read more in this perspective article.
This article discusses the indications for adjuvant radiotherapy in melanoma, in terms of both the primary site and lymph node regions.
Explore the potential role of the inflammatory tumor microenvironment in resistance to melanoma therapy in this peer-reviewed article from Melanoma Management.